Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2005-09-21
2009-11-03
Canella, Karen A (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S327000, C530S328000, C514S002600, C514S014800, C514S015800
Reexamination Certificate
active
07612162
ABSTRACT:
The invention provides a peptide derived from the interleukin-13 receptor α2, which serves as a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope. The invention can be used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use. In addition, the invention provides the use of a peptide derived from the Eph family of tyrosine kinase receptors which can be also used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use.
REFERENCES:
patent: 7338929 (2008-03-01), Debinski et al.
patent: 2002/0182219 (2002-12-01), Debinski et al.
patent: WO 95/22317 (1995-08-01), None
patent: WO 96/18409 (1996-06-01), None
patent: WO 01/58479 (2001-08-01), None
patent: WO 01/62979 (2001-08-01), None
Yamanaka and Itoh (Expert Opinion Bio. Ther. 2007 7(5): 645-649).
Neeson and Paterson (Immunological Investigations, 2006, 35:359-94).
Boon (Adv Can Res, 1992, 58:177-210).
Marincola et al. (Trends in Immunology, Jun. 2003, 334-341).
Sherman et al, (Critical Reviews in Immunol. 1998, 18:47-54).
Smith (Clin. Immunol, 1994, 41(4): 841-849).
Berzofsky (ASM News, 2004, 70:219-223).
Kirkin et al (1998, APMIS, 106 : 665-679).
Greenspan et al. (Nature Biotechnology 7:936-937 (1999).
Schreier et al. (Nucl Acids Res. 14:2381-2389 (1986)).
Kouklis PD et al. (1993, J Cell Science, 106 (pt 3): 919-28).
Dorland's Illustrated Medical Dictionary: Vaccine, 2007.
Byers, T. (CA Journal, vol. 49, No. 6, Nov./Dec. 1999).
Cotterchio et al, 2000, Chronic Diseases in Canada, (Electronic Version downloaded from www.phac-aspc.gc.ca/publicat/cdic- mcc/21-2/f—e.html).
Gura (Science, 1997, 278:1041-1042).
Kaiser (Science, 2006, 313, 1370).
Okano et al., “Identification of a Novel HLA-A 0201-Restricted, Cytotoxic T Lymphocyte Epitope in a Human Glioma-Associated Antigen, Interleukin 13 Receptor α2 Chain,”Clinical Cancer Research, 8(9): 2851-2855 (Sep. 2002).
Annex to Form PCT/ISA/206 Communication Relating to the Results of the Partial International Search dated Apr. 3, 2006, in PCT/US2005/033794.
Alves et al.,Cancer Research, 63: 8476-8480 (Dec. 1, 2003).
Bakker et al.,Cancer Research, 55: 5330-5334 (Nov. 15, 1995).
Bigner et al.,Journal of Neurosurgery, 55: 32-42 (Jul. 1981).
Bownds et al.,Journal of Immunotherapy, 24(1): 1-9 (Jan./Feb. 2001).
Brantley et al.,Oncogene, 21(46): 7011-7026 (Oct. 10, 2002).
Carmon et al.,The Journal of Clinical lnvestifgation, 110(4): 453-462 (Aug. 2002).
Chen et al.,The Journal of Immunology, 165(2): 948-955 (Jul. 15, 2000).
Debinski et al.,International Journal of Oncology, 15: 481-486 (1999).
Debinski et al.,Molecular Medicine, 6(5): 440-449 (May 2000).
Debinski et al.,Journal of Neuro-Oncology, 48: 103-111 (2000).
Francini et al.,The Journal of Immunology, 169(9): 4840-4849 (Nov. 1, 2002).
Graff-Dubois et al.,The Journal of Immunology, 169: 575-580(2002) .
Greten et al.,Journal of Immunological Methods, 271: 125-135 (2002).
Gross et al.,The Journal of Clinical Investigation, 113(3): 425-433 (Feb. 2004).
Hatano et al.,Journal of Translational Medicine, 2(40): 1-9 (2004).
Herrem et al.,Clinical Cancer Research, 11(1): 226-231 (Jan. 1, 2005).
Kinch et al.,Clinical&Experimental Metastasis, 20: 59-68 (2003).
Lupetti et al.,The Journal of Experimental Medicine, 188(6): 1005-1016 (Sep. 21, 1998).
Ogawa et al.,Oncogene, 19(52): 6043-6052 (Dec. 7, 2000).
Okada et al.,International Journal of Cancer, 78(1): 196-201 (Sep. 25, 1998).
Okada et al.,Human Gene Therapy, 12(5): 575-595 (Mar. 20, 2001).
Okada et al.,Gene Therapy, 8(15): 1157-1166 (Aug. 2001).
Okada et al.,Journal of Neuro-Oncology, 64(1-2): 13-20 (Aug./Sep. 2003).
Okano et al.,Clinical Cancer Research, 8(9): 2851-2855 (Sep. 2002).
Pascolo et al.,The Journal of Experimental Medicine, 185(12): 2043-2051 (Jun. 16, 1997).
Riker et al.,Surgery, 126(1): 112-120 (Jul. 1999).
Scardino et al.,The Journal of Immunology, 169: 5900-5906 (2002).
Tatsumi et al.,Cancer Research, 63: 4481-4489 (Aug. 1, 2003).
Wen et al.,Neurology and Neuroscience Reports, 4(3): 218-227 (May 2004).
Yu et al.,Cancer Research, 64(14): 4973-4979 (Jul. 15, 2004).
Zelinski et al.,Cancer Research, 61: 2301-2306 (Mar. 1, 2001).
Eguchi Junichi
Okada Hideho
Sato Hidemitsu
Storkus Walter J.
Canella Karen A
Leydig , Voit & Mayer, Ltd.
Reddig Peter J
University of Pittsburgh - Of the Commonwealth System of Higher
LandOfFree
Peptide analogs capable of enhancing stimulation of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide analogs capable of enhancing stimulation of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide analogs capable of enhancing stimulation of a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4066481